National Vaccine Information Center Your Health. Your Family. Your Choice.

MedAlerts Home

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amnesia, Muscle twitching, Muscular weakness, Nausea, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02669

Write-up: Information has been received from an agency (local reference No. NZL/11/0105) concerning a patient (age and gender unknown) who an unknown date was vaccinated with a dose of GARDASIL (lot number, route and dose not reported). On an unspecified date the patient experienced nausea, faintness, muscle weakness, twitching and memory loss. At the time of reporting the patient had not recovered. Nausea, faintness, muscle weakness, twitching and memory loss were considered to be disabling by the agency. The reporter felt that nausea, faintness, muscle weakness, twitching and memory loss were related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.

Changed on 6/14/2014

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amnesia, Muscle twitching, Muscular weakness, Nausea, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02669

Write-up: Information has been received from an agency (local reference No. NZL/11/0105) concerning a patient (age and gender unknown) who an unknown date was vaccinated with a dose of GARDASIL (lot number, route and dose not reported). On an unspecified date the patient experienced nausea, faintness, muscle weakness, twitching and memory loss. At the time of reporting the patient had not recovered. Nausea, faintness, muscle weakness, twitching and memory loss were considered to be disabling by the agency. The reporter felt that nausea, faintness, muscle weakness, twitching and memory loss were related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.

Changed on 3/14/2015

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amnesia, Muscle twitching, Muscular weakness, Nausea, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02669

Write-up: Information has been received from an agency (local reference No. NZL/11/0105) concerning a patient (age and gender unknown) who an unknown date was vaccinated with a dose of GARDASIL (lot number, route and dose not reported). On an unspecified date the patient experienced nausea, faintness, muscle weakness, twitching and memory loss. At the time of reporting the patient had not recovered. Nausea, faintness, muscle weakness, twitching and memory loss were considered to be disabling by the agency. The reporter felt that nausea, faintness, muscle weakness, twitching and memory loss were related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.

Changed on 9/14/2017

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amnesia, Muscle twitching, Muscular weakness, Nausea, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02669

Write-up: Information has been received from an agency (local reference No. NZL/11/0105) concerning a patient (age and gender unknown) who an unknown date was vaccinated with a dose of GARDASIL (lot number, route and dose not reported). On an unspecified date the patient experienced nausea, faintness, muscle weakness, twitching and memory loss. At the time of reporting the patient had not recovered. Nausea, faintness, muscle weakness, twitching and memory loss were considered to be disabling by the agency. The reporter felt that nausea, faintness, muscle weakness, twitching and memory loss were related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.

Changed on 2/14/2018

Administered by: Unknown      Purchased by: Unknown
Symptoms: Amnesia, Muscle twitching, Muscular weakness, Nausea, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1111USA02669

Write-up: Information has been received from an agency (local reference No. NZL/11/0105) concerning a patient (age and gender unknown) who an unknown date was vaccinated with a dose of GARDASIL (lot number, route and dose not reported). On an unspecified date the patient experienced nausea, faintness, muscle weakness, twitching and memory loss. At the time of reporting the patient had not recovered. Nausea, faintness, muscle weakness, twitching and memory loss were considered to be disabling by the agency. The reporter felt that nausea, faintness, muscle weakness, twitching and memory loss were related to therapy with GARDASIL. The original reporting source was not provided. No further information is available.

New Search